{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T03:04:13Z","timestamp":1790305453917,"version":"4.1.0"},"reference-count":94,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.bioorg.2025.109444","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T23:43:14Z","timestamp":1767051794000},"page":"109444","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Pyrazole derivatives as dual COX-2\/EGFR inhibitors with anticancer potential: Optimization of difenamizole Analogs"],"prefix":"10.1016","volume":"170","author":[{"given":"Kawther O.","family":"Farag","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai S.","family":"Nour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai M.","family":"Abdelhafez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noha M.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatem A.","family":"Abdel-Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samar H.","family":"Fahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2025.109444_bb0005","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20174262","article-title":"Cyclo-oxygenase (COX) inhibitors and cardiovascular risk: are non-steroidal anti-inflammatory drugs really anti-inflammatory?","volume":"20","author":"Khan","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.109444_bb0010","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1161\/ATVBAHA.110.207449","article-title":"Prostaglandins and inflammation","volume":"31","author":"Ricciotti","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bioorg.2025.109444_bb0015","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1016\/j.apsb.2022.01.002","article-title":"Recent development on COX-2 inhibitors as promising anti-inflammatory agents: the past 10 years","volume":"12","author":"Ju","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bioorg.2025.109444_bb0020","doi-asserted-by":"crossref","first-page":"C188","DOI":"10.1152\/ajpcell.2001.281.1.C188","article-title":"COX-2 expression and cell cycle progression in human fibroblasts","volume":"281","author":"Gilroy","year":"2001","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.bioorg.2025.109444_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105663","article-title":"Inflammation: biochemistry, cellular targets, anti-inflammatory agents and challenges with special emphasis on cyclooxygenase-2","volume":"121","author":"Kaur","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.109444_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21072605","article-title":"Anti-inflammatory drugs as anticancer agents","volume":"21","author":"Zappavigna","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.109444_bb0035","article-title":"Role of nonsteroidal anti-inflammatory drugs (NSAIDs) in Cancer prevention and Cancer promotion","volume":"2019","author":"Wong","year":"2019","journal-title":"Adv. Pharmacol. Sci."},{"key":"10.1016\/j.bioorg.2025.109444_bb0040","first-page":"1705","article-title":"Recategorization of non-aspirin nonsteroidal anti-inflammatory drugs according to clinical relevance: abandoning the traditional NSAID terminology","volume":"37","author":"Bonnesen","year":"2021","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.bioorg.2025.109444_bb0045","first-page":"3029","article-title":"New ibuprofen derivatives as H2S and NO donors as safer anti-inflammatory agents., future","volume":"11","author":"Hassan","year":"2019","journal-title":"Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109444_bb0050","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1002\/ddr.21992","article-title":"Nonacidic thiophene-based derivatives as potential analgesic and design, synthesis, biological evaluation, and metabolic stability study","volume":"83","author":"Mikhail","year":"2022","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.bioorg.2025.109444_bb0055","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2147\/JAA.S164806","article-title":"NSAID-induced reactions: classification, prevalence, impact, and management strategies","volume":"12","author":"Blanca-Lopez","year":"2019","journal-title":"J. Asthma Allergy"},{"key":"10.1016\/j.bioorg.2025.109444_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117631","article-title":"Structural investigation on the selective COX-2 inhibitors mediated cardiotoxicity: a review","volume":"251","author":"Arora","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.bioorg.2025.109444_bb0065","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1111\/bcp.13048","article-title":"Cardiovascular effects of cyclooxygenase-2 inhibitors: a mechanistic and clinical perspective","volume":"82","author":"Patrono","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.109444_bb0070","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/FJC.0b013e3182010a96","article-title":"Effects of selective cyclooxygenase-2 and nonselective cyclooxygenase inhibition on myocardial function and perfusion","volume":"57","author":"Robich","year":"2011","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.109444_bb0075","doi-asserted-by":"crossref","first-page":"983","DOI":"10.2147\/TCRM.S3209","article-title":"Risk management profile of etoricoxib: an example of personalized medicine","volume":"4","author":"Patrignani","year":"2008","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.bioorg.2025.109444_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23010134","article-title":"Synthesis and pharmacological activities of pyrazole derivatives: a review","volume":"23","author":"Karrouchi","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2025.109444_bb0085","article-title":"Insights into microwave-promoted synthesis of 3-methyl-4-phenyl-4,9-dihydro-1H-pyrazolo[3,4-d][1,2,4]triazolo[1,5-a]pyrimidine derivatives catalyzed using new Pd (II),Cu (II),VO (II), and Ag(I) complexes as a heterogeneous catalyst and computational studi","volume":"38","author":"El-Remaily","year":"2024","journal-title":"Appl. Organomet. Chem."},{"key":"10.1016\/j.bioorg.2025.109444_bb0090","article-title":"Investigation of the anti-inflammatory and analgesic activities of promising pyrazole derivative","volume":"168","author":"Bekhit","year":"2022","journal-title":"Eur. J. Pharm. Sci. Off. J. Eur. Fed. Pharm. Sci."},{"key":"10.1016\/j.bioorg.2025.109444_bb0095","first-page":"1643","article-title":"Recent advances in the development of Pyrazolopyridines as anticancer agents., anticancer. Agents","volume":"22","author":"Gu","year":"2022","journal-title":"Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109444_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ddr.70168","article-title":"Design, Synthesis, and 2D QSAR analysis of some novel pyrazolo[1,5-a]pyrimidine derivatives as Pim-1 kinase inhibitors for the treatment of MCF-7 breast Cancer","volume":"86","author":"Mohammed","year":"2025","journal-title":"Drug dev. Res."},{"key":"10.1016\/j.bioorg.2025.109444_bb0105","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1080\/14756366.2020.1742116","article-title":"Design, synthesis, molecular modelling and biological evaluation of novel 3-(2-naphthyl)-1-phenyl-1H-pyrazole derivatives as potent antioxidants and 15-lipoxygenase inhibitors","volume":"35","author":"Ali","year":"2020","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109444_bb0110","doi-asserted-by":"crossref","first-page":"3480","DOI":"10.1016\/j.ejmech.2009.01.032","article-title":"Synthesis of novel pyrazole derivatives and evaluation of their antidepressant and anticonvulsant activities","volume":"44","author":"Abdel-Aziz","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109444_bb0115","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2174\/0115680266280249240126052505","article-title":"Pyrazoline derivatives as promising MAO-A targeting antidepressants: an update","volume":"24","author":"Choudhary","year":"2024","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109444_bb0120","doi-asserted-by":"crossref","first-page":"S2073","DOI":"10.1016\/j.arabjc.2013.07.037","article-title":"Synthesis and anticonvulsant activity of some 2-pyrazolines derived from chalcones","volume":"10","author":"Beyhan","year":"2017","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.bioorg.2025.109444_bb0125","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3389\/fphys.2018.01073","article-title":"The newly synthesized pyrazole derivative 5-(1-(3 fluorophenyl)-1H-Pyrazol-4-yl)-2H-tetrazole reduces blood pressure of spontaneously hypertensive rats via NO\/cGMO pathway","volume":"9","author":"Trindade","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.bioorg.2025.109444_bb0130","doi-asserted-by":"crossref","first-page":"703","DOI":"10.22146\/ijc.70243","article-title":"Design, synthesis, and anti-mycobacterial evaluation of new 3,5-disubstituted-pyrazole-1-carbothioamides","volume":"22","author":"Wong","year":"2022","journal-title":"Indones. Jouranal Chem."},{"key":"10.1016\/j.bioorg.2025.109444_bb0135","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27154723","article-title":"Recent applications of the multicomponent synthesis for bioactive pyrazole derivatives","volume":"27","author":"Becerra","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2025.109444_bb0140","doi-asserted-by":"crossref","first-page":"17446","DOI":"10.1021\/acsomega.3c00692","article-title":"Design and development of COX-II inhibitors: current scenario and future perspective., ACS","volume":"8","author":"Chahal","year":"2023","journal-title":"Omega"},{"key":"10.1016\/j.bioorg.2025.109444_bb0145","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0028-3908(78)90108-9","article-title":"Effects of 1,3-diphenyl-5-(2-dimethylaminopropionamide)-pyrazole[difenamizole] on a conditioned avoidance response","volume":"17","author":"Kameyama","year":"1978","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bioorg.2025.109444_bb0150","first-page":"907","article-title":"Effect of monoamine-related drugs on the inhibitory effect of difenamizole on acetic acid writhing","volume":"73","author":"Toshitaka Nabeshima","year":"1977","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.109444_bb0155","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1248\/cpb.26.3265","article-title":"Inhibitory effect of difenamizole on morphine-induced straub tail reaction with special reference to monoaminergic agents","volume":"26","author":"Kameyama","year":"1978","journal-title":"Chem. Pharm. Bull. (Tokyo)."},{"key":"10.1016\/j.bioorg.2025.109444_bb0160","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12935-015-0260-7","article-title":"Cyclooxygenase-2 promotes tumor growth and suppresses tumor immunity","volume":"15","author":"Liu","year":"2015","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bioorg.2025.109444_bb0165","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/2048731","article-title":"Cyclooxygenase-2: a role in Cancer stem cell survival and repopulation of Cancer cells during therapy","volume":"2016","author":"Pang","year":"2016","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.bioorg.2025.109444_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.137495","article-title":"Multifunctional lanthanum oxide-doped carboxymethyl cellulose nanocomposites: a promising approach for antimicrobial and targeted anticancer applications","volume":"283","author":"Khalil","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bioorg.2025.109444_bb0175","first-page":"677","article-title":"Cyclooxygenase-2 and the inflammogenesis of breast cancer., world","volume":"5","author":"Harris","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bioorg.2025.109444_bb0180","first-page":"5031","article-title":"Apricoxib, a novel inhibitor of COX-2, markedly improves standard therapy response in molecularly defined models of pancreatic cancer., clin. Cancer res. An off. J. Am. Assoc","volume":"18","author":"Kirane","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2025.109444_bb0185","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.drudis.2016.09.017","article-title":"Cyclooxygenase-2 in glioblastoma multiforme","volume":"22","author":"Qiu","year":"2017","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bioorg.2025.109444_bb0190","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1055\/s-0042-1758864","article-title":"Clinicopathological and prognostic significance of COX-2 in glioma patients: a meta-analysis","volume":"80","author":"Wang","year":"2022","journal-title":"Arq. Neuropsiquiatr."},{"key":"10.1016\/j.bioorg.2025.109444_bb0195","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.3892\/ol.2017.6281","article-title":"Expression and clinical significance of cyclooxygenase 2 and survivin in human gliomas","volume":"14","author":"Zhang","year":"2017","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bioorg.2025.109444_bb0200","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.18632\/oncotarget.1370","article-title":"COX-2 overexpression increases malignant potential of human glioma cells through Id1","volume":"5","author":"Xu","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.bioorg.2025.109444_bb0205","first-page":"4926","article-title":"Expression of cyclooxygenase 2 (COX-2) in human glioma and in vitro inhibition by a specific COX-2 inhibitor, NS-398","volume":"60","author":"Joki","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2025.109444_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2022.119359","article-title":"Control of cell metabolism by the epidermal growth factor receptor","volume":"1869","author":"Orofiamma","year":"2022","journal-title":"Biochim. Biophys. Acta. Mol. Cell Res."},{"key":"10.1016\/j.bioorg.2025.109444_bb0215","doi-asserted-by":"crossref","first-page":"22","DOI":"10.5301\/ijbm.5000301","article-title":"EGFR as a clinical marker in glioblastomas and other gliomas","volume":"33","author":"Saadeh","year":"2018","journal-title":"Int. J. Biol. Markers"},{"issue":"Suppl. 1","key":"10.1016\/j.bioorg.2025.109444_bb0220","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1038\/onc.2009.198","article-title":"Activating and resistance mutations of EGFR in non-small-cell lung cancer: role in clinical response to EGFR tyrosine kinase inhibitors","volume":"28","author":"Gazdar","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.bioorg.2025.109444_bb0225","first-page":"71","article-title":"Prognostic significance of EGFR gene amplification and overexpression in diffuse Astrocytomas \u2014 a literature, open","volume":"2","author":"Hagen","year":"2012","journal-title":"J. Pathol."},{"key":"10.1016\/j.bioorg.2025.109444_bb0230","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1021\/jm0613166","article-title":"Structural and functional basis of cyclooxygenase inhibition","volume":"50","author":"Blobaum","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109444_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103023","article-title":"Design, synthesis, modeling studies and biological screening of novel pyrazole derivatives as potential analgesic and anti-inflammatory agents","volume":"89","author":"Taher","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.109444_bb0240","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1055\/a-1323-2813","article-title":"Piperazine: a promising scaffold with analgesic and anti-inflammatory potential","volume":"71","author":"Jain","year":"2021","journal-title":"Drug Res. (Stuttg)."},{"key":"10.1016\/j.bioorg.2025.109444_bb0245","doi-asserted-by":"crossref","first-page":"6121","DOI":"10.1158\/0008-5472.CAN-07-0141","article-title":"EGFR activation results in enhanced cyclooxygenase-2 expression through p38 mitogen-activated protein kinase-dependent activation of the Sp1\/Sp3 transcription factors in human gliomas","volume":"67","author":"Xu","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2025.109444_bb0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/03009740310004766","article-title":"Selective cyclooxygenase-2 inhibitors: similarities and differences","volume":"33","author":"Brune","year":"2004","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.bioorg.2025.109444_bb0255","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27041158","article-title":"EGFR and COX-2 dual inhibitor: the design, synthesis, and biological evaluation of novel chalcones","volume":"27","author":"Musa","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2025.109444_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117340","article-title":"Optimization of pyrazole\/1,2,4-triazole as dual EGFR\/COX-2 inhibitors: design, synthesis, anticancer potential, apoptosis induction and cell cycle analysis","volume":"287","author":"Kahk","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109444_bb0265","article-title":"New pyrazolyl-thiazolidinone\/thiazole derivatives as celecoxib\/dasatinib analogues with selective COX-2, HER-2 and EGFR inhibitory effects: design, synthesis, anti-inflammatory\/anti-proliferative activities, apoptosis, molecular modelling and ADME studie","volume":"38","author":"Fadaly","year":"2023","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109444_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111693","article-title":"New oxadiazoles with selective-COX-2 and EGFR dual inhibitory activity: design, synthesis, cytotoxicity evaluation and in silico studies","volume":"183","author":"El-Sayed","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109444_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105302","article-title":"Novel 1,5-diaryl pyrazole-3-carboxamides as selective COX-2\/sEH inhibitors with analgesic, anti-inflammatory, and lower cardiotoxicity effects","volume":"116","author":"Hendawy","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.109444_bb0280","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1007\/s00280-012-1854-6","article-title":"Phase I study of AEE788, a novel multitarget inhibitor of ErbB- and VEGF-receptor-family tyrosine kinases, in recurrent glioblastoma patients","volume":"69","author":"Reardon","year":"2012","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.109444_bb0285","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.2174\/0929867311320160001","article-title":"Recent advances in drug design of epidermal growth factor receptor inhibitors","volume":"20","author":"Warnault","year":"2013","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109444_bb0290","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13765-021-00651-0","article-title":"Effect of a novel piperazine compound on cancer cells","volume":"64","author":"Jeon","year":"2021","journal-title":"Appl. Biol. Chem."},{"key":"10.1016\/j.bioorg.2025.109444_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111879","article-title":"Substituted 4-phenylthiazoles: development of potent and selective a(1), a(3) and dual a(1)\/a(3) adenosine receptor antagonists","volume":"186","author":"Abdelrahman","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109444_bb0300","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.ejmech.2014.10.076","article-title":"Mannich bases in medicinal chemistry and drug design","volume":"89","author":"Roman","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109444_bb0305","first-page":"856","article-title":"Design, synthesis, and biological evaluation of new 2-(4-(methylsulfonyl)phenyl)-N-phenylimidazo[1,2-a]pyridin-3-amine as selective COX-2 inhibitors","volume":"32","author":"Movahed","year":"2023","journal-title":"Med. Chem. Res. an Int. J. Rapid Commun. Des. Mech. Action Biol. Act. Agents"},{"key":"10.1016\/j.bioorg.2025.109444_bb0310","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ejmech.2016.04.028","article-title":"2-Aryl-3-(2-morpholinoethyl)thiazolidin-4-ones: synthesis, anti-inflammatory in vivo, cytotoxicity in vitro and molecular docking studies","volume":"118","author":"Pires Gouvea","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109444_bb0315","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1016\/j.bmc.2019.07.033","article-title":"COX-1\/COX-2 inhibition activities and molecular docking study of newly designed and synthesized pyrrolo[3,4-c]pyrrole Mannich bases","volume":"27","author":"Redzicka","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109444_bb0320","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252212401","article-title":"Rhodanine-piperazine hybrids as potential VEGFR, EGFR, and HER2 targeting anti-breast Cancer agents","volume":"25","author":"Szczepa\u0144ski","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.109444_bb0325","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28073014","article-title":"Discovery of Novel EGFR Inhibitor Targeting Wild-Type and Mutant Forms of EGFR: In Silico and In Vitro Study","volume":"28","author":"Todsaporn","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2025.109444_bb0330","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1080\/00397911.2021.1910846","article-title":"Deadly KCN and pricey metal free track for accessing \u03b2-ketonitriles employing mild reaction conditions","volume":"51","author":"Sharma","year":"2021","journal-title":"Synth. Commun."},{"key":"10.1016\/j.bioorg.2025.109444_bb0335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2013.03.063","article-title":"Synthesis of pyrazolo[1,5-a][1,3,5]triazine derivatives as inhibitors of thymidine phosphorylase","volume":"65","author":"Sun","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109444_bb0340","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.2147\/DDDT.S118297","article-title":"Synthesis, anti-inflammatory, analgesic, COX1\/2-inhibitory activity, and molecular docking studies of hybrid pyrazole analogues","volume":"10","author":"Alam","year":"2016","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.bioorg.2025.109444_bb0345","first-page":"495","article-title":"One-pot three-component synthesis, in vitro anticancer activity and p53-MDM2 protein-protein interaction inhibition of novel spiro-oxindoline-based pyrazolo[3,4-b]pyridines","volume":"67","author":"Allam","year":"2023","journal-title":"Egypt. J. Chem."},{"key":"10.1016\/j.bioorg.2025.109444_bb0350","article-title":"Rapidly, highly yielded and green synthesis of Dihydrotetrazolo[1,5-a]pyrimidine derivatives in aqueous media using recoverable pd(II) thiazole catalyst accelerated by ultrasonic: computational studies","author":"El-Remaily","year":"2021","journal-title":"Appl. Organomet. Chem."},{"key":"10.1016\/j.bioorg.2025.109444_bb0355","doi-asserted-by":"crossref","first-page":"35934","DOI":"10.1039\/C5RA05779E","article-title":"Vilsmeier\u2013Haack reagent-promoted formyloxylation of \u03b1-chloro-N-arylacetamides by formamide","volume":"5","author":"Huang","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2025.109444_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111651","article-title":"Neurobehavioral investigation and acetylcholinesterase inhibitory activity study for some new coumarin derivatives","volume":"182","author":"Mahmoud","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109444_bb0365","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/ardp.200300823","article-title":"The synthesis and anticonvulsant activity of some \u03c9-phthalimido-N-phenylacetamide and propionamide derivatives","volume":"337","author":"Soyer","year":"2004","journal-title":"Arch. Pharm. (Weinheim)."},{"key":"10.1016\/j.bioorg.2025.109444_bb0370","doi-asserted-by":"crossref","DOI":"10.1002\/aoc.7262","article-title":"Efficiency and development of guanidine chelate catalysts for rapid and green synthesis of 7-amino-4,5-dihydro-tetrazolo[1,5-a]pyrimidine-6-carbonitrile derivatives supported by density functional theory (DFT) studies","volume":"37","author":"El-Remaily","year":"2023","journal-title":"Appl. Organomet. Chem."},{"key":"10.1016\/j.bioorg.2025.109444_bb0375","first-page":"7","article-title":"Development of novel guanidine Iron (III) complexes as a powerful catalyst for the synthesis of tetrazolo[1,5-a]pyrimidine by green protocol","volume":"9","author":"El-Remaily","year":"2023","journal-title":"Sohag J. Sci."},{"key":"10.1016\/j.bioorg.2025.109444_bb0380","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11113009","article-title":"Nerve growth factor, antimicrobial peptides and chemotherapy: glioblastoma combination therapy to improve their efficacy","volume":"11","author":"Chernov","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.bioorg.2025.109444_bb0385","doi-asserted-by":"crossref","first-page":"849","DOI":"10.32604\/or.2024.047042","article-title":"A review on potential heterocycles for the treatment of glioblastoma targeting receptor tyrosine kinases","volume":"32","author":"Nilam Bhusare","year":"2024","journal-title":"Oncol. Res."},{"key":"10.1016\/j.bioorg.2025.109444_bb0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2025.142571","article-title":"Exploring, anthranilic azomethine complexes: from synthesis, spectroscopic, solution and theoretical studies to DNA interaction and biomedical prospects","volume":"1341","author":"Abu-Dief","year":"2025","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2025.109444_bb0395","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/384644a0","article-title":"Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents","volume":"384","author":"Kurumbail","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2025.109444_bb0400","doi-asserted-by":"crossref","first-page":"46265","DOI":"10.1074\/jbc.M207135200","article-title":"Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor","volume":"277","author":"Stamos","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2025.109444_bb0405","doi-asserted-by":"crossref","first-page":"5074","DOI":"10.1007\/s00044-014-1090-1","article-title":"In silico molecular docking study of natural compounds on wild and mutated epidermal growth factor receptor","volume":"23","author":"Singh","year":"2014","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2025.109444_bb0410","doi-asserted-by":"crossref","first-page":"7779","DOI":"10.3390\/ijms21207779","article-title":"Ligand-based pharmacophore Modeling, molecular docking, and molecular dynamic studies of dual tyrosine kinase inhibitor of EGFR and VEGFR2","volume":"21","author":"Sangande","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.109444_bb0415","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.1021\/jm400072p","article-title":"Protein kinase inhibitor design by targeting the asp-Phe-Gly (DFG) motif: the role of the DFG motif in the design of epidermal growth factor receptor inhibitors","volume":"56","author":"Peng","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109444_bb0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107760","article-title":"Discovery of novel thiazole derivatives containing pyrazole scaffold as PPAR-\u03b3 agonists, \u03b1-glucosidase, \u03b1-amylase and COX-2 inhibitors; design, synthesis and in silico study","volume":"152","author":"Fadaly","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.109444_bb0425","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jep.2004.08.035","article-title":"Analgesic and anti-inflammatory activity of a crude root extract of Pfaffia glomerata (Spreng) Pedersen","volume":"96","author":"Neto","year":"2005","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.bioorg.2025.109444_bb0430","doi-asserted-by":"crossref","first-page":"W513","DOI":"10.1093\/nar\/gkae303","article-title":"ProTox 3.0: a webserver for the prediction of toxicity of chemicals","volume":"52","author":"Banerjee","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bioorg.2025.109444_bb0435","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1254\/fpj.73.961","article-title":"Effects of difenamizole on behavior maintained by schedule of positive reinforcement","volume":"73","author":"Nabeshima","year":"1977","journal-title":"Nihon Yakurigaku Zasshi."},{"key":"10.1016\/j.bioorg.2025.109444_bb0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2025.142060","article-title":"A robust synthesis, physicochemical characterization, stability determination and potential biomedical applications of novel Salen complexes supported by theoretical approaches","volume":"1336","author":"Al-Ghamdi","year":"2025","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2025.109444_bb0445","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20190994","article-title":"SP1-DLEU1-miR-4429 feedback loop promotes cell proliferative and anti-apoptotic abilities in human glioblastoma","volume":"39","author":"Liu","year":"2019","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.bioorg.2025.109444_bb0450","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1007\/s11696-022-02136-w","article-title":"Simulation for the behavior of new Fe(III) and Cr(III)-thiophenyl complexes towards DNA polymerase: synthesis, characterization, eukaryotic DNA and Hartree\u2013Fock computation","volume":"76","author":"Alatawi","year":"2022","journal-title":"Chem. Pap."},{"key":"10.1016\/j.bioorg.2025.109444_bb0455","article-title":"Innovation of some novel complexes based on Synthesis , structural elucidation DFT calculation and pharmaceutical studies","volume":"38","author":"Hessah","year":"2024","journal-title":"Appl. Organomet. Chem."},{"key":"10.1016\/j.bioorg.2025.109444_bb0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115918","article-title":"Design and synthesis of certain 7-Aryl-2-Methyl-3-substituted pyrazolo{1,5-a}pyrimidines as multikinase inhibitors","volume":"262","author":"Al-Qadhi","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109444_bb0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2025.128738","article-title":"Fabrication, structural analysis, stability determination, DNA interaction, and biomedical potential of some novel water-soluble schiff base complexes","volume":"438","author":"Alharbi","year":"2025","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.bioorg.2025.109444_bb0470","article-title":"Design and synthesis of tunable schiff base complexes from bis-(2-oxoindolin-3-ylidene)anthracene-9,10-dione: integrated structural, biological, and molecular modeling insights","volume":"120","author":"Abu-Dief","year":"2026","journal-title":"Comput. Biol. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825013240?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825013240?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T21:13:09Z","timestamp":1770066789000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825013240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":94,"alternative-id":["S0045206825013240"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109444","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pyrazole derivatives as dual COX-2\/EGFR inhibitors with anticancer potential: Optimization of difenamizole Analogs","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109444","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109444"}}